No delayed restenosis at 18 months after implantation of sirolimus-eluting stent

Catheter Cardiovasc Interv. 2002 Sep;57(1):65-8. doi: 10.1002/ccd.10266.

Abstract

Sirolimus-eluting stent is emerging as a potential solution for the prevention of restenosis. Recently, a sustained suppression of neointimal proliferation 12 months after implantation of this stent was reported. This is the first report of angiographic and IVUS images 18 months after the implantation of a sirolimus-eluting stent.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Vessel Prosthesis Implantation
  • Coated Materials, Biocompatible / therapeutic use
  • Combined Modality Therapy
  • Coronary Angiography
  • Coronary Restenosis / drug therapy*
  • Coronary Restenosis / etiology*
  • Device Removal
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Sirolimus / therapeutic use*
  • Stents*
  • Time Factors
  • Ultrasonography, Interventional

Substances

  • Coated Materials, Biocompatible
  • Immunosuppressive Agents
  • Sirolimus